Biofrontera Balance Sheet Health
Financial Health criteria checks 6/6
Biofrontera has a total shareholder equity of €20.0M and total debt of €1.1M, which brings its debt-to-equity ratio to 5.7%. Its total assets and total liabilities are €30.7M and €10.8M respectively. Biofrontera's EBIT is €4.8M making its interest coverage ratio -797. It has cash and short-term investments of €3.1M.
Key information
5.7%
Debt to equity ratio
€1.15m
Debt
| Interest coverage ratio | -797x |
| Cash | €3.08m |
| Equity | €19.98m |
| Total liabilities | €10.75m |
| Total assets | €30.73m |
Recent financial health updates
We're Keeping An Eye On Biofrontera's (ETR:B8F) Cash Burn Rate
Feb 19
Does Biofrontera (ETR:B8F) Have A Healthy Balance Sheet?
Jun 08Recent updates
Why Investors Shouldn't Be Surprised By Biofrontera AG's (ETR:B8F) 30% Share Price Plunge
Mar 07We're Keeping An Eye On Biofrontera's (ETR:B8F) Cash Burn Rate
Feb 19Here's Why It's Unlikely That Biofrontera AG's (ETR:B8F) CEO Will See A Pay Rise This Year
Dec 07Does Biofrontera (ETR:B8F) Have A Healthy Balance Sheet?
Jun 08Biofrontera AG (ETR:B8F) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Apr 14Financial Position Analysis
Short Term Liabilities: B8F's short term assets (€17.7M) exceed its short term liabilities (€10.1M).
Long Term Liabilities: B8F's short term assets (€17.7M) exceed its long term liabilities (€679.0K).
Debt to Equity History and Analysis
Debt Level: B8F has more cash than its total debt.
Reducing Debt: B8F's debt to equity ratio has reduced from 83.3% to 5.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: B8F has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: B8F is forecast to have sufficient cash runway for 7 months based on free cash flow estimates, but has since raised additional capital.